Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Mar 5;25(5):1165.
doi: 10.3390/molecules25051165.

Interaction of Coumarin Phytoestrogens with ERα and ERβ: A Molecular Dynamics Simulation Study

Ting Wang  1 , Yunfei Wang  1 , Xuming Zhuang  1 , Feng Luan  1 , Chunyan Zhao  2 , M Natália D S Cordeiro  3
Affiliations

Interaction of Coumarin Phytoestrogens with ERα and ERβ: A Molecular Dynamics Simulation Study

Ting Wang et al. Molecules. .

Abstract

Coumarin phytoestrogens, as one of the important classes of phytoestrogens, have been proved to play an important role in various fields of human life. In this study, molecular simulation method including molecular docking and molecular dynamics methods were performed to explore the various effects between four classical coumarin phytoestrogens (coumestrol, 4-methoxycoumestrol, psoralen and isopsoralen), and estrogen receptors (ERα, ERβ), respectively. The calculated results not only proved that the four coumarin phytoestrogens have weaker affinity than 17β-estradiol to both ERα, and ERβ, but also pointed out that the selective affinity for ERβ is greater than ERα. In addition, the binding mode indicated that the formation of hydrogen bond and hydrophobic interaction have an important effect on the stability of the complexes. Further, the calculation and decomposition of binding free energy explored the main contribution interactions to the total free energy.

Keywords: binding free energy; coumarin; estrogen receptor; molecular dynamics simulation; phytoestrogens.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Chemical structure of four coumarin phytoestrogens: (a) coumestrol, (b) 4-methoxycoumestrol, (c) psoralen, (d) isopsoralen as well as (e) 17β-estradiol.
Figure 2
Figure 2
RMSD values of ER-ligand complexes in 100 ns MD simulation (a) in the ERα system, (b) in the ERβ system.
Figure 3
Figure 3
RMSDvalues of the four coumarin phytoestrogens as well as 17β-estradiol (a) in the ERα system, (b) in the ERβ system.
Figure 4
Figure 4
RMSF values of ER-ligand complexes in 100 ns MD simulation (a) in the ERα system, (b) in the ERβ system.
Figure 5
Figure 5
Interaction between ligands and proteins: (a) in the ERα system; (b) in the ERβ system.
Figure 5
Figure 5
Interaction between ligands and proteins: (a) in the ERα system; (b) in the ERβ system.
Figure 6
Figure 6
Hydrophobic interaction of complexes, the color from red to blue indicates a decrease in hydrophobic potential.
Figure 6
Figure 6
Hydrophobic interaction of complexes, the color from red to blue indicates a decrease in hydrophobic potential.
Figure 7
Figure 7
Contribution of key amino acids to binding free energy in the ERα system. Black part: van der Waals and non-polar solvation energy; gray part: electrostatic energy and polar solvation energy. The positive values in the Figure are not conducive to the binding of the ligand to the receptor, and the negative value facilitates the binding of the ligand to the receptor.
Figure 8
Figure 8
Contribution of key amino acids to binding free energy in the ERβ system. Black part: van der Waals and non-polar solvation energy; gray part: electrostatic energy and polar solvation energy. The positive values in the figure are not conducive to the binding of the ligand to the receptor, and the negative value facilitates the binding of the ligand to the receptor.
See this image and copyright information in PMC

References

    1. Ososki A.L., Kennelly E.J. Phytoestrogens: A review of the present state of research. Phytother. Res. 2003;17:845–869. doi: 10.1002/ptr.1364. - DOI - PubMed
    1. Adlercreutz H. Phyto-oestrogens and cancer. Lancet Oncol. 2002;3:364–373. doi: 10.1016/S1470-2045(02)00777-5. - DOI - PubMed
    1. Gaynor M.L. Isoflavones and the prevention and treatment of prostate disease: Is there a role? Cleve. Clin. J. Med. 2003;70:203–204. doi: 10.3949/ccjm.70.3.203. - DOI - PubMed
    1. Van Der Schouw Y.T., Raats M., Groot L.D., Staveren W.V. Phytoestrogens and the health of older women. Food Ageing Popul. 2009;21:430–457.
    1. Lecomte S., Lelong M., Bourgine G., Efstathiou T., Saligaut C., Pakdel F. Assessment of the potential activity of major dietary compounds as selective estrogen receptor modulators in two distinct cell models for proliferation and differentiation. Toxicol. Appl. Pharmacol. 2017;325:61–70. doi: 10.1016/j.taap.2017.04.005. - DOI - PubMed

LinkOut - more resources